Select Transactions
|
Global collaboration for the development and commercialization of ODM-208 with |
|
$290 million upfront
July 2022
|
|
Sale to |
|
$260 million
August 2021
|
|
Sale of 100% equity stake to |
|
$106 million + milestones
June 2021
|
|
Equity investment from |
|
$200 million
February 2021
|
Torreya is a leading strategic M&A advisor to global life sciences companies.
MORE
Torreya is one of the most active financial advisors on pharmaceutical-product asset sales.
MORE
Torreya’s Capital Markets team arranges debt financings, royalty monetizations, IPOs, and private equity recapitalizations.
MORE
Torreya is a leading advisor on pre-commercial and commercial-stage licensing deals.
MORE